Q&A: How would you integrate corneal hysteresis into your glaucoma management?

Video

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part four.

Related: Q&A: What is corneal hysteresis?

Related to his technology article in the July 2022 issue of Optometry Times®, Thomas A. Wong, OD, FNAP, associate clinical professor of SUNY Optometry, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, both members of the SUNY Optometry class of 2022, discuss corneal hysteresis.

Related: Corneal hysteresis and biomechanics growing in diagnostic importance

This transcript has been lightly edited for clarity:

How would you integrate corneal hysteresis into your glaucoma management?

Kelly Armstrong, OD:

So since we're just about to graduate in a few weeks, the way I would integrate into my clinical management is if I have a new glaucoma patient — either they haven't been diagnosed yet, or I'm thinking about maybe changing up their treatment — and I'm on the borderline, I would get a corneal hysteresis to help me make that decision factor at the end if I would start them on treatment or add an additional drop going forward.

Related: Q&A: How is corneal hysteresis measured?

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
Brett Bielory, MD, at ASCRS 2025
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
© 2025 MJH Life Sciences

All rights reserved.